Form 4: Recursion Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Najat Khan, Chief R&D Commercial Officer at Recursion Pharmaceuticals, disposed of shares to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On May 15, 2025, Najat Khan, Chief R&D Commercial Officer of Recursion Pharmaceuticals, disposed of 3,796 shares of Class A Common Stock at a price of $4.25 per share to cover tax obligations.
- Following the transaction, Khan directly owns 708,585 shares of Class A Common Stock.
- Khan also holds options to purchase 420,226 shares at $7.25, vesting monthly from March 1, 2025, and options to purchase 993,944 shares at $7.34, vesting quarterly from July 1, 2025, and then monthly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects a routine transaction for tax purposes and doesn't indicate any fundamental change in the company's prospects or the executive's confidence.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This filing indicates that an executive disposed of shares to cover tax obligations, which is a common practice.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/03/2035 | Expiration date for stock options to buy 420,226 shares at $7.25. |
| 08/01/2034 | Expiration date for stock options to buy 993,944 shares at $7.34. |
| 03/01/2025 | Start date for monthly vesting of stock options to buy 420,226 shares at $7.25. |
| 05/15/2025 | Date of transaction where 3,796 shares were disposed of to cover tax obligations. |
| 07/01/2025 | Start date for quarterly vesting of stock options to buy 993,944 shares at $7.34. |
| 05/19/2025 | Date of signature for the Form 4 filing. |
Keywords
Recursion Pharmaceuticals, Najat Khan, Form 4, Stock Options, Share Disposal, Tax Withholding, RXRX, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.